Rajasthan Cancer Cure Hospital Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 1.51 M
- Company Age 29 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -68.26%
- Profit Growth -61.06%
- Ebitda -78.76%
- Net Worth 15.64%
- Total Assets -17.35%
About Rajasthan Cancer Cure Hospital
Rajasthan Cancer Cure Hospital Private Limited (RCCHPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 October 1995 and has a history of 29 years and three months. Its registered office is in Jodhpur, Rajasthan, India.
The Corporate was formerly known as Rajasthan Cancer Cure Hospital Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.51 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Sanchetee and Amita Sanchetee serve as directors at the Company.
Company Details
-
Location
Jodhpur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110RJ1995PTC010941
-
Company No.
010941
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Oct 1995
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Rajasthan Cancer Cure Hospital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Sanchetee
|
Director | 18-Oct-1995 | Current |
|
Amita Sanchetee
|
Director | 18-Oct-1995 | Current |
Financial Performance of Rajasthan Cancer Cure Hospital.
Rajasthan Cancer Cure Hospital Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 68.26% decrease. The company also saw a substantial fall in profitability, with a 61.06% decrease in profit. The company's net worth Soared by an impressive increase of 15.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajasthan Cancer Cure Hospital?
In 2021, Rajasthan Cancer Cure Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rajasthan Cancer Cure Hospital?
Rajasthan Cancer Cure Hospital has a workforce of 2 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajasthan Cancer Cure Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajasthan Cancer Cure Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
